FindTrial
Sign In

To study efficacy of Rasayana therapy in management of cancer related fatigue

Prospective observational two arm study to evaluate efficacy of Rasayana therapy in management of cancer related fatigue (CRF) based on patientâ??s reported outcome in Real world.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/05/033832
Enrollment
60
Registered
2021-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R530- Neoplastic (malignant) related fatigue

Interventions

Intervention1: Rasayana therapy: Rasayana therapy in management of fatigue

Sponsors

Rasayu Cancer Clinic
Lead Sponsor
Rasayu Cancer Clinic Pune
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1 Cancer patients of any type and stage who will report moderate to severe fatigue. (FSS scale- score more than 4 ) 2 ECOG equal or more than 2

Exclusion criteria

Exclusion criteria: 1 Patient who is on other conventional treatment or nutritional supplements for Fatigue 2 Patient receiving steroid therapy

Design outcomes

Primary

MeasureTime frame
To assess efficacy of Rasayana in the management of CRF by using FSS scale and its impact on quality of life by using Fact G-Version 4 Timepoint: Day 0 Day 30 Day 60 Day 90—

Secondary

MeasureTime frame
To assess ECOG performance status and QOL in CRF patientâ??s pre and post Rasayana therapy Timepoint: Baseline Day 30 Day 60 Day 90—

Countries

India

Contacts

Public ContactDr Yogesh Bendale

Rasayu Cancer Clinic

dr.bendale@gmail.com02024537149

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026